| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO & President | Director
1 company
Sandra Yvette Campos last filed a Form 4 in April 2025, as CEO & President at PETS. Sandra Yvette Campos's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 578,524 shares of PETS. The PETS filings lean toward selling, a net 60,463 shares.
Sandra Yvette Campos has 4 Form 4 filings on record from August 2023 to April 2025, all as CEO & President at Petmed Express (PETS), 2023–2025.
The 6 reported transactions were 3 stock awards, 2 open-market sales and 1 option or other derivative award.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $200K.
The only open-market sale was 60,463 shares of PETS at an average $3.31 on April 30, 2025, about $200K. Twelve months later PETS was down 34%.
Shares as reported in the last Form 4 for each company; the most recent is from April 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2025 | PETS Petmed Express Inc | CEO & President | Sell | 60,463 | $3.31 | $200,090.24 | -9.5% | -4.7% | -33.7% |